Related Experiment Video
Updated: Sep 30, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
[Neuromuscular blockade with cisatracurium in infants andchildren. Its course under sevoflurane anesthesia]
S Soltész1, M Silomon, T Mencke
1Klinik für Anästhesie und operative Intensivmedizin, Klinikum Leverkusen gGmbH, Dhünnberg 60, 51375 Leverkusen. soltesz@klinikum-lev.de
Insights
Infants show greater sensitivity to cisatracurium, with faster onset and longer duration of neuromuscular blockade compared to children. Neuromuscular monitoring is recommended in pediatric anesthesia due to interindividual variability.
Area of Science:
- Anesthesiology
- Pharmacology
- Pediatric Medicine
Background:
- Cisatracurium is a neuromuscular blocking agent used in anesthesia.
- Understanding age-related differences in drug response is crucial for safe pediatric anesthesia.
Purpose of the Study:
- To compare the onset, duration, and maximum effect of cisatracurium (0.1 mg/kg) in infants and children undergoing balanced anesthesia.
Main Methods:
- Electromyography was used to measure neuromuscular blockade in 15 infants and 15 children.
- Anesthesia was maintained with sevoflurane and remifentanil.
- Key parameters including onset time, clinical duration, and recovery index were recorded.
Main Results:
- Infants exhibited a significantly shorter onset time (74 s vs. 198 s) and longer clinical duration (55 min vs. 41 min) of cisatracurium compared to children.
- Recovery of the train-of-four ratio to 90% (TOFR 0.9) was longer in infants (73 min vs. 59 min).
- Maximum neuromuscular blockade (Tmax) was higher in infants (100% vs. 98%).
Conclusions:
- Infants are more sensitive to cisatracurium than children, showing faster onset, prolonged duration, and delayed recovery.
- Significant interindividual differences necessitate routine neuromuscular monitoring in pediatric anesthesia.
Objective:
To compare the onset, duration and maximum effect of 0.1 mg/kg cisatracurium during balanced anesthesia with sevoflurane and remifentanil between infants and children.
Methods:
We measured the time course of the neuromuscular blockade in 15 infants and 15 children by electromyography. Anesthesia was induced with propofol/remifentanil and maintained with sevoflurane (constant 2% endtidal) and remifentanil according to the patients individual requirements. After injection of 0.1 mg/kg cisatracurium we measured the following parameters: onset time: time between the beginning of injection of cisatracurium and maximum T1 depression, clinical duration: time between injection of the drug and recovery of T1 to 25%, recovery index: time between recovery of T1 from 25% to 75%. TOFR 0.9: time between injection of cisatracurium and recovery of the train-of-four ratio to 90%. In addition, we determined the maximum neuromuscular blockade Tmax after 0.1 mg/kg cistracurium.
Results:
Both groups differed significantly with regard to onset time and clinical duration. In the infants, the onset time was shorter (74 s vs. 198 s) and the clinical duration longer (55 min vs. 41 min) compared to the older children. The TOFR 0.9 was 73 min (range 56-86 min) in the group of the infants and 59 min (range 43-72 min) in the group of the older children (p < 0.001). Tmax was 100% (range 97-100%) in the infants and 98% (range 92-100%) in the children (p < 0.01). However, the recovery index was comparable in both groups (21 vs. 16 min).
Conclusions:
Infants are substantially more sensitive to cisatracurium than children, which can be demonstrated in a significantly shorter onset time, a prolonged clinical duration and a delayed neuromuscular recovery. As there exist large interindividual differences, we recommend the use of neuromuscular monitoring in the routine practice of pediatric anesthesia.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Pharmocokinetics
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
